Peter Vanderslice
12Patents
3h-index
13Co-inventors
57Inventor score
Filing activity: Jul 7, 1994 → Jun 29, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5510332A | Process to inhibit binding of the integrin .alpha..sub.4 62 .sub.1 to VCAM-1 or fibronectin and linear peptides therefor | Human Necessities | 72 | Expired |
| US6087330A | Process to inhibit binding of the integrin .alpha..sub.4 .beta..sub.1 to VCAM-1 or fibronectin and cyclic peptides therefor | Human Necessities | 20 | Expired |
| US6713604B1 | Process to inhibit binding of the integrin &agr;4&bgr;1 , to VCAM-1 fibronectin and cyclic peptides thereof | Human Necessities | 6 | Expired |
| US9512109B2 | Agonists that enhance binding of integrin-expressing cells to integrin receptors | Chemistry; Metallurgy | 3 | Active |
| US10709780B2 | Integrin activator vaccine compositions | Chemistry; Metallurgy | 2 | Active |
| US10716849B2 | Methods of administering novel integrin activator vaccine compositions | Chemistry; Metallurgy | 2 | Active |
| US10342866B2 | Compositions and methods for immunotherapies comprising small molecule integrin receptor-ligand agonist adjuvants | Chemistry; Metallurgy | 1 | Active |
| US11311619B2 | Integrin activator vaccine compositions | Chemistry; Metallurgy | 1 | Active |
| US10709781B2 | Integrin activator checkpoint inhibitor compositions | Chemistry; Metallurgy | 1 | Active |
| US10287264B2 | Agonists that enhance binding of integrin-expressing cells to integrin receptors | Chemistry; Metallurgy | 0 | Active |
| US11312685B2 | Targeting nanoparticles | Human Necessities | 0 | Active |
| US12201686B2 | Compositions including a therapeutic antibodies and/or a checkpoint inhibitor and an integrin activating compound | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.